Skip to main content
. 2022 Feb 17;97(3):315–320. doi: 10.1016/j.abd.2021.08.003

Table 2.

Treated sites and outcomes of repigmentation in our patients.

Treated sites Frequency Outcome of repigmentation
Good to excellent Poor to moderate p-value
Upper extremity Fingers, n (%) 15 (78.9%) 7 (46.7%) 8 (53.3%)
Dorsal of hand 3 (15.8%) 2 (66.7%) 1 (33.3%)
Forearm 1 (5.3%) 0 (0.0%) 1 (100.0%)
Total 19 (100.0%) 9 (47.4%) 10 (52.6%)
Face and neck, n (%)
Cheek 9 (21.9%) 7 (77.8%) 2 (22.2%)
Lower lid 8 (19.5%) 5 (62.5%) 3 (37.5%)
Forehead 6 (14.6%) 6 (100.0%) 0 (0.0%)
Neck 6 (14.6%) 3 (50.0%) 3 (50.0%)
Chin 3 (7.3%) 2 (66.7%) 1 (33.3%)
Upper lid 3 (7.3%) 2 (66.7%) 1 (33.3%) 0.001
Upper lip 2 (4.9%) 2 (100.0%) 0 (0.0%)
Temple 2 (4.9%) 2 (100.0%) 0 (0.0%)
Lateral face 2 (4.9%) 2 (100.0%) 0 (0.0%)
Total 41 (100%) 31(75.6%) 10 (24.4%)
Trunk, n (%)
Chest 12 (32.4%) 2 (16.7%) 10(83.3%)
Flank 8 (21.6%) 2 (25.0%) 6 (75.0%)
Abdomen 7 (18.9%) 3 (42.9%) 4 (57.1%)
Back 6 (16.2%) 2 (33.3%) 4 (66.7%)
Shoulder 4 (10.8%) 2 (50.0%) 2 (50.0%)
Total 37 (100%) 11 (29.7%) 26 (70.3%)
Genital areas, n (%) 11 (100.0%) 3 (27.3%) 8 (72.7%)
Total 11 (100.0%) 3 (27.3%) 8 (72.7%)
All treated areas 108(100.0%) 54(50.0%) 54 (50.0.0%)